Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease

  title={Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease},
  author={Daniel J. Cameron and Lorraine B. Johnson and Elizabeth L. Maloney},
  journal={Expert Review of Anti-Infective Therapy},
  pages={1103 - 1135}
Evidence-based guidelines for the management of patients with Lyme disease were developed by the International Lyme and Associated Diseases Society (ILADS). The guidelines address three clinical questions – the usefulness of antibiotic prophylaxis for known tick bites, the effectiveness of erythema migrans treatment and the role of antibiotic retreatment in patients with persistent manifestations of Lyme disease. Healthcare providers who evaluate and manage patients with Lyme disease are the… 

Antibiotic prophylaxis for prevention against Lyme disease following tick bite: an updated systematic review and meta-analysis

The available evidence supports the use of antibiotics for the prevention of Lyme disease, and reveals advantages of using single-dose; however, further confirmation is needed.

The Controversies, Challenges and Complexities of Lyme Disease: A Narrative Review.

  • M. Van Hout
  • Medicine
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • 2018
Despite growing global incidence of the Lyme disease, treatment has not attracted pharmaceutical investment, and the evidence base and international guidelines for treatment and management of chronic Lyme continue to be conflicting and controversial.

Evidence-Based, Patient-Centered Treatment of Erythema Migrans in the United States

The US trial evidence regarding EM rashes is reviewed, the shortcomings of the IDSA/AAN/ACR recommendations in light of that evidence are discussed and evidence-based, patient-centered strategies for managing patients with erythema migrans lesions are offered.

Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society

This guideline of the German Dermatology Society primarily focuses on the diagnosis and treatment of cutaneous manifestations of Lyme borreliosis and makes recommendations for confirming a clinical diagnosis, recommendations for a stage-related laboratory diagnosis and recommendations for the treatment of the late-stage infection.

Practical aspects of Lyme disease in children

Lyme disease is especially important in the spring–autumn period, despite the fact that its clinical manifestations may be throughout the year. Awareness of general practitioners with this problem is

Chronic Lyme Disease: A Working Case Definition

A working case definition of CLD is presented based on analysis of more than 700 peer-reviewed publications that indicates chronic Lyme disease is a multisystem illness with diverse musculoskeletal, neuropsychiatric and/or cardiovascular manifestations that result from ongoing infection with pathogenic members of the Borrelia spirochete complex.

The Role of the Infectious Disease Consultation in Lyme Disease.

  • Jean Dejace
  • Medicine, Biology
    Infectious disease clinics of North America
  • 2022

Guidelines for diagnosis and treatment in neurology – Lyme neuroborreliosis

The main objectives of this guideline are to define the disease and to give recommendations for the confirmation of a clinically suspected diagnosis by laboratory testing, antibiotic therapy, differential diagnostic testing and prevention.

Are Mycobacterium Drugs Effective for Treatment Resistant Lyme Disease, Tick-Borne Co-Infections, and Autoimmune Disease?

The novel use of another mycobacterium drug, pyrazinamide, (PZA), is reported on in relieving resistant symptomatology secondary to Lyme disease and associated co-infections, while decreasing autoimmune manifestations with Behçet’s syndrome.

Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2

Results indicate that dapsone combination therapy decreased the severity of eight major Lyme symptoms, and multiple sources of inflammation along with downstream effects of inflammation may all affect chronic symptomatology.



The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

These updated guidelines replace the previous treatment guidelines published in 2000 and list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease and provide a partial list of therapies to be avoided.

Diagnostic challenges of early Lyme disease: Lessons from a community case series

Failure to recognize erythema migrans or alternatively, viral-like presentations without a rash, can lead to missed or delayed diagnosis of Lyme disease, ineffective antibiotic treatment, and the potential for late manifestations.

Lyme Disease and the Orthopaedic Implications of Lyme Arthritis

Lyme arthritis is a common clinical manifestation of Lyme disease and should be considered in the evaluation of patients with monoarticular or pauciarticular joint complaints in a geographic area in which Lyme disease is endemic.

Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease, and treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo.

Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial.

A significant gain in the QOL for subjects randomized to amoxicillin in this RCT without serious adverse events is consistent with the goal of improving patient's QOL and consequently worthy of further study.

Protective value of prophylactic antibiotic treatment of tick bite for Lyme disease prevention: an animal model.

Surveillance for Lyme disease--United States, 1992-2006.

The results presented in this report underscore the continued emergence of Lyme disease and the need for tick avoidance and early treatment interventions and can be used to target prevention campaigns to populations with increasing incidence.

Duration of Antibiotic Therapy for Early Lyme Disease

Oral doxycycline alone for 10 days is sufficient treatment for patients with early Lyme disease that manifests as erythema migrans, and the outcome of therapy might be enhanced by treatment with a parenteral agent such as ceftriaxone, which readily crosses the bloodbrain barrier.

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis.

The available evidence to date supports the use of antibiotic prophylaxis for the prevention of Lyme disease in endemic areas following an Ixodes tick bite, and pooled data from four placebo-controlled trials suggests that one case of Lyme Disease is prevented for about every 50 patients who are treated with antibiotics.